Pressure BioSciences, Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details) - $ / shares		12 Months Ended
	Nov. 10, 2011	Dec. 31, 2016	Dec. 31, 2015
Expected life (in months)	60 months
Expected volatility	104.50%
Risk-free interest rate	0.875%
Exercise price	$ 0.81
Fair value per share	$ 0.54
Warrants Revalued at December 31, 2015 [Member]
Expected life (in months)			11 months
Expected volatility			104.90%
Risk-free interest rate			0.65%
Exercise price			$ .25
Fair value per share			0.16
Warrants Revalued at December 31, 2016 [Member]
Expected life (in months)		5 months
Expected volatility		83.50%
Risk-free interest rate		0.62%
Exercise price		$ 0.25
Fair value per share		$ 0.02
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate		1.93%
Exercise price		$ 0.40	0.40
Fair value per share			$ 0.30
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		43 months	55 years
Expected volatility		110.00%	136.30%
Risk-free interest rate			1.29%
Fair value per share		$ 0.12
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		51 months	60 years
Expected volatility		116.00%	141.60%
Risk-free interest rate			1.76%
Fair value per share		$ 0.14
Issuance Fair Value [Member] \| Minimum [Member]
Expected life (in months)		6 months
Expected volatility		104.20%
Risk-free interest rate		0.05%
Exercise price		$ 0.10
Fair value per share		$ 0.09
Issuance Fair Value [Member] \| Maximum [Member]
Expected life (in months)		24 months
Expected volatility		153.80%
Risk-free interest rate		0.99%
Exercise price		$ 0.35
Fair value per share		$ 0.28
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member]
Expected life (in months)		60 months
Exercise price		$ 0.40
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected volatility		118.30%
Risk-free interest rate		1.48%
Fair value per share		$ 0.19
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected volatility		120.10%
Risk-free interest rate		1.69%
Fair value per share		$ 0.21
At Settlement Fair Value [Member] \| Minimum [Member]
Expected life (in months)		0 months
Expected volatility		86.90%
Risk-free interest rate		0.01%
Exercise price		$ 0.10
Fair value per share		$ 0.07
At Settlement Fair Value [Member] \| Maximum [Member]
Expected life (in months)		18 months
Expected volatility		142.20%
Risk-free interest rate		0.72%
Exercise price		$ 0.25
Fair value per share		0.26
Conversion Options Revalued at December 31, 2015 [Member]
Exercise price			$ 0.28
Conversion Options Revalued at December 31, 2015 [Member] \| Minimum [Member]
Expected life (in months)			18 years
Expected volatility			112.20%
Fair value per share			$ 0.33
Conversion Options Revalued at December 31, 2015 [Member] \| Maximum [Member]
Expected life (in months)			24 years
Expected volatility			114.70%
Fair value per share			$ 0.14
Conversion Options Revalued at December 31, 2016 [Member]
Exercise price		$ 0.28
Conversion Options Revalued at December 31, 2016 [Member] \| Minimum [Member]
Expected life (in months)		6 months
Expected volatility		84.40%
Risk-free interest rate		0.62%
Fair value per share		$ 0.03
Conversion Options Revalued at December 31, 2016 [Member] \| Maximum [Member]
Expected life (in months)		15 months
Expected volatility		94.80%
Risk-free interest rate		0.85%
Fair value per share		$ 0.06